Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008601
Filing Date
2020-05-14
Accepted
2020-05-14 08:23:14
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 446505
2 ex31-1.htm EX-31.1 17314
3 ex31-2.htm EX-31.2 17462
4 ex32-1.htm EX-32.1 9712
  Complete submission text file 0001493152-20-008601.txt   3306820

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ghsi-20200331.xml EX-101.INS 543393
6 XBRL SCHEMA FILE ghsi-20200331.xsd EX-101.SCH 54508
7 XBRL CALCULATION FILE ghsi-20200331_cal.xml EX-101.CAL 51781
8 XBRL DEFINITION FILE ghsi-20200331_def.xml EX-101.DEF 180510
9 XBRL LABEL FILE ghsi-20200331_lab.xml EX-101.LAB 337916
10 XBRL PRESENTATION FILE ghsi-20200331_pre.xml EX-101.PRE 249474
Mailing Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128 858-605-9055
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

EIN.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38861 | Film No.: 20875372
SIC: 2834 Pharmaceutical Preparations